Creative Medical Technology Holdings, (NASDAQ:CELZ) declares IRB Approval to proceed with its Clinical Trial for the treatment of Type 1 Diabetes
According to cnn: In early 2020, as they tried to fight covid-19 across two rural counties in North Carolina, the…